ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction.
Anna BenedettiChiara TurcoEnzo GalloTheodora DaraliotiAndrea SacconiClaudio PulitoSara DonzelliClaudia TitoMartina DragonettiLetizia PerracchioGiovanni BlandinoFrancesco FaziGiulia FontemaggiPublished in: Cell death & disease (2024)
Understanding the mechanisms of breast cancer cell communication underlying cell spreading and metastasis formation is fundamental for developing new therapies. ID4 is a proto-oncogene overexpressed in the basal-like subtype of triple-negative breast cancer (TNBC), where it promotes angiogenesis, cancer stem cells, and BRACA1 misfunction. Here, we show that ID4 expression in BC cells correlates with the activation of motility pathways and promotes the production of VEGFA, which stimulates the interaction of VEGFR2 and integrin β3 in a paracrine fashion. This interaction induces the downstream focal adhesion pathway favoring migration, invasion, and stress fiber formation. Furthermore, ID4/ VEGFA/ VEGFR2/ integrin β3 signaling stimulates the nuclear translocation and activation of the Hippo pathway member's YAP and TAZ, two critical executors for cancer initiation and progression. Our study provides new insights into the oncogenic roles of ID4 in tumor cell migration and YAP/TAZ pathway activation, suggesting VEGFA/ VEGFR2/ integrin β3 axis as a potential target for BC treatment.
Keyphrases
- cell migration
- vascular endothelial growth factor
- cancer stem cells
- breast cancer cells
- induced apoptosis
- endothelial cells
- poor prognosis
- papillary thyroid
- biofilm formation
- stem cells
- transcription factor
- cell therapy
- risk assessment
- pseudomonas aeruginosa
- bone marrow
- cystic fibrosis
- binding protein
- signaling pathway
- squamous cell
- stress induced